Status:
COMPLETED
Optimal Screening Program in Detecting Stenosis and Predicting Thrombosis in Hemodialysis Graft
Lead Sponsor:
Azienda Ospedaliera Universitaria Integrata Verona
Conditions:
Arteriovenous Graft Stenosis
Arteriovenous Graft Thrombosis
Eligibility:
All Genders
18+ years
Brief Summary
A well-functioning vascular access is essential for providing adequate life-sustaining treatment in patients with end stage renal disease on maintenance hemodialysis. The preferred long-term vascular ...
Detailed Description
A well-functioning vascular access (a system that allows the blood of the patient to leave the body, be brought to the artificial kidney or dialyzer to be cleaned and return the cleansed blood to the ...
Eligibility Criteria
Inclusion
- All the patients with a polytetrafluroethylene (PTFE) graft as haemodialysis vascular access who were treated at the haemodialysis Unit of the Polyclinic of B.go Roma Hospital in Verona during the recruitment period and who agreed to take part at the study
Exclusion
- No one.
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2018
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT03839264
Start Date
August 1 2011
End Date
September 30 2018
Last Update
February 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera Integrata di Verona - Policlinico Borgo Roma
Verona, Italy, 37135